Acrobot Pursues Orthopedic Partners In Multiple Markets
This article was originally published in The Gray Sheet
Executive Summary
Acrobot is seeking a partner to help market its line of "intelligent surgical tools" in the U.S. orthopedic implant surgery market beginning in 2009
You may also be interested in...
People Briefs: Wright Medical; Reapplix APS; Sotera Wireless
Wright Medical Group appoints Kevin Cordell president, U.S. extremities; wound therapy patch developer Reapplix names CEO; Sotera Wireless taps senior VP, sales and marketing.
Acrobot/Corin
Corin Group will distribute Acrobot's Acrobot Navigation electromagnetic navigation system for hip resurfacing surgeries in the UK, Germany and Australia. Under the agreement announced May 27, Corin will buy the systems from Acrobot and market them alongside its Cormet hip resurfacing system.The agreement is London-based Acrobot's first commercial route-to-market agreement. Corin and Acrobot have been cooperating to adapt Acrobot's system for hip resurfacing since 2004, and at the end of 2007 Corin owned about 10% of the company. Acrobot's other partners include Biomet, Stanmore Implants and the Imperial College London
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.